Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ATM mutation
i
Other names:
ATM, ATA, ATC, ATD, ATDC, TEL1, TELO1, ATM serine/threonine kinase
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
472
Related biomarkers:
Expression
Mutation
CNA
Others
‹
ATM deletion + SF3B1 mutation (4)
Chr del(11q) + ATM mutation (2)
ATM expression + ATM T2333fs* + EGFR negative (1)
BRCA2 deletion + ATM mutation (1)
ATM deletion + SF3B1 mutation (4)
Chr del(11q) + ATM mutation (2)
ATM expression + ATM T2333fs* + EGFR negative (1)
BRCA2 deletion + ATM mutation (1)
›
Related tests:
FoundationOne® CDx (110)
FoundationOne® Liquid CDx (21)
FoundationOne® CDx (110)
FoundationOne® Liquid CDx (21)
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ATM mutation
Prostate Cancer
ATM mutation
Prostate Cancer
olaparib
Sensitive: A1 - Approval
olaparib
Sensitive
:
A1
olaparib
Sensitive: A1 - Approval
olaparib
Sensitive
:
A1
ATM mutation
Squamous Cell Carcinoma of Head and Neck
ATM mutation
Squamous Cell Carcinoma of Head and Neck
durvalumab + tremelimumab-actl
Sensitive: B - Late Trials
durvalumab + tremelimumab-actl
Sensitive
:
B
durvalumab + tremelimumab-actl
Sensitive: B - Late Trials
durvalumab + tremelimumab-actl
Sensitive
:
B
ATM mutation
Breast Cancer
ATM mutation
Breast Cancer
ribociclib
Resistant: B - Late Trials
ribociclib
Resistant
:
B
ribociclib
Resistant: B - Late Trials
ribociclib
Resistant
:
B
ATM mutation
Chronic Lymphocytic Leukemia
ATM mutation
Chronic Lymphocytic Leukemia
obinutuzumab
Resistant: B - Late Trials
obinutuzumab
Resistant
:
B
obinutuzumab
Resistant: B - Late Trials
obinutuzumab
Resistant
:
B
ATM mutation
Ovarian Cancer
ATM mutation
Ovarian Cancer
olaparib
Sensitive: B - Late Trials
olaparib
Sensitive
:
B
olaparib
Sensitive: B - Late Trials
olaparib
Sensitive
:
B
ATM mutation
Solid Tumor
ATM mutation
Solid Tumor
Immunotherapy
Sensitive: B - Late Trials
Immunotherapy
Sensitive
:
B
Immunotherapy
Sensitive: B - Late Trials
Immunotherapy
Sensitive
:
B
ATM mutation
Prostate Cancer
ATM mutation
Prostate Cancer
rucaparib
Sensitive: B - Late Trials
rucaparib
Sensitive
:
B
rucaparib
Sensitive: B - Late Trials
rucaparib
Sensitive
:
B
ATM mutation
Chronic Lymphocytic Leukemia
ATM mutation
Chronic Lymphocytic Leukemia
zanubrutinib
Sensitive: B - Late Trials
zanubrutinib
Sensitive
:
B
zanubrutinib
Sensitive: B - Late Trials
zanubrutinib
Sensitive
:
B
ATM mutation
Lung Adenocarcinoma
ATM mutation
Lung Adenocarcinoma
olaparib
Sensitive: C1 - Off-label
olaparib
Sensitive
:
C1
olaparib
Sensitive: C1 - Off-label
olaparib
Sensitive
:
C1
ATM mutation
Pancreatic Cancer
ATM mutation
Pancreatic Cancer
olaparib
Sensitive: C1 - Off-label
olaparib
Sensitive
:
C1
olaparib
Sensitive: C1 - Off-label
olaparib
Sensitive
:
C1
ATM mutation
Pancreatic Ductal Adenocarcinoma
ATM mutation
Pancreatic Ductal Adenocarcinoma
olaparib
Sensitive: C1 - Off-label
olaparib
Sensitive
:
C1
olaparib
Sensitive: C1 - Off-label
olaparib
Sensitive
:
C1
ATM mutation
Urothelial Cancer
ATM mutation
Urothelial Cancer
olaparib
Sensitive: C1 - Off-label
olaparib
Sensitive
:
C1
olaparib
Sensitive: C1 - Off-label
olaparib
Sensitive
:
C1
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.